PHI with Menopausal syndrome
How does this condition affect your private health insurance?
Klimakterisches Syndrom, or Menopausal Syndrome, encompasses a range of symptoms women experience due to declining estrogen during perimenopause and menopause. Common manifestations include hot flashes, night sweats, mood swings, sleep disturbances, vaginal dryness, and fatigue. While a natural physiological transition, its severity varies significantly, impacting daily life and well-being. It is not a disease but a phase that can be managed to alleviate discomfort. Long-term health implications like increased osteoporosis and cardiovascular disease risk are associated with post-menopausal hormonal changes, rather than the acute syndrome itself. Treatment often involves lifestyle adjustments, hormone replacement therapy, or other symptomatic interventions.
PKV Risk Assessment
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several years (during perimenopause and initial post-menopause)
Duration of Illness (Lifetime)
Chronic during a specific life phase, typically 5-10 years, but can be longer for some symptoms
Cost of Treatment (Initial)
Moderate (e.g., lifestyle changes, supplements, medical consultations, potential HRT costs annually)
Cost of Treatment (Lifetime)
Moderate to high (can accumulate to several thousands of dollars over the entire symptomatic period, depending on interventions)
Mortality Rate
Extremely low (not directly causative)
Risk of Secondary Damages
High (e.g., increased risk of osteoporosis, cardiovascular issues post-menopause, psychological distress like depression or anxiety, sleep disorders, vaginal atrophy)
Probability of Full Recovery
High (symptoms generally resolve over time, though some post-menopausal conditions like osteoporosis risk or vaginal atrophy may persist or require ongoing management)
Underlying Disease Risk
Moderate (e.g., increased risk of cardiovascular disease, osteoporosis, depression, anxiety can coexist or be exacerbated during this period)